Navigation Links
Accuray Announces Four New Products at Nation's Leading Radiation Oncology Meeting
Date:10/29/2007

e world's only robotic radiosurgery system designed to treat tumors anywhere in the body non-invasively and with sub-millimeter accuracy. Using continual image guidance technology and computer controlled robotic mobility, the CyberKnife System automatically tracks, detects and corrects for tumor and patient movement in real-time throughout the treatment. This enables the CyberKnife System to deliver precise, high-dose radiation, minimizing damage to surrounding healthy tissue and eliminating the need for invasive head or body stabilization frames.

About Accuray

Accuray Incorporated (Nasdaq: ARAY), based in Sunnyvale, Calif., is a global leader in the field of radiosurgery dedicated to providing an improved quality of life and a non-surgical treatment option for those diagnosed with cancer. Accuray develops and markets the CyberKnife Robotic Radiosurgery System, which extends the benefits of radiosurgery to include extracranial tumors, including those in the spine, lung, prostate, liver and pancreas. To date, the CyberKnife System has been used to treat more than 35,000 patients worldwide and currently more than 100 systems have been installed in leading hospitals in the Americas, Europe and Asia. For more information, please visit http://www.accuray.com.

Safe Harbor Statement

The foregoing may contain certain forward-looking statements that involve risks and uncertainties, including uncertainties associated with the medical device industry. Except for the historical information contained herein, the matters set forth in this press release regarding procedure growth and market acceptance, clinical studies, regulatory review and approval, and commercial
'/>"/>

SOURCE Accuray Incorporated
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. PM announces a new health care order for India
2. Ramdoss Announces Introduction of RCH-II
3. Britain Announces Third Transfusion Related Mad Cow Case
4. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
5. Tibet Announces the Dalai Lama’s Tour of South Americ
6. NHS announces further Cost cutting Measures
7. Indian PM Announces Of Setting Up India Study Center At Tashkent
8. PowderMed Announces Needle-Less Flu Vaccine
9. Malaysia Announces Prison term On People Donating HIV-Contaminated Blood
10. Australian Government Announces Survey To Tackle Childhood Obesity
11. New Zealand Announces 10-year Plan For Betterment Of Mental Health Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/26/2008)...an farm, FDA announces , , FRIDAY, July...ering the first big clue in the nationwide salmone...ay that tainted jalapeno peppers had been definiti...d and Drug Administration gave the all-clear to ja...tes, but warned consumers to avoid any raw jalapen...
(Date:7/25/2008)...ter & Olsen LLP has filed a,class action lawsuit a...,"Company") (Nasdaq: ARTC ) and certain of its of...District of Texas on behalf of all persons or,enti...m January 24, 2008,through July 18, 2008 (the "Com... or entities who purchased call options or sold pu...
(Date:7/25/2008)...inancial results -, LAVAL, QC, July 25 /PRNewswir...DSS) today announced that it will host a conferenc...scuss its second quarter 2008,financial results. L...cial,results via news release at approximately 7:0...ll by telephone, dial 416-646-3095 or,1-800-814-48...
(Date:7/25/2008)...FirstCall/ -- Thoratec,Corporation (Nasdaq: THOR ...atory support therapies to save, support and resto...port its operating results for the second,quarter ...uly 31., The company will hold a conference call ...ivities to all interested parties at 1:30 p.m.,Pa...
Breaking Medicine News(10 mins):Health News:Mexican Peppers ID'd as Salmonella Culprits 2Health News:Mexican Peppers ID'd as Salmonella Culprits 3Health News:Klafter & Olsen LLP Announces That It Has Filed a Class Action Lawsuit Against ArthroCare Corporation on Behalf of Common Stock Holders and Certain Traders in ArthroCare Options 2Health News:Klafter & Olsen LLP Announces That It Has Filed a Class Action Lawsuit Against ArthroCare Corporation on Behalf of Common Stock Holders and Certain Traders in ArthroCare Options 3Health News:Labopharm to host conference call Friday, August 8, 2008 at 8:30 A.M. (ET) 2Health News:Thoratec Schedules Second Quarter 2008 Conference Call, Webcast 2
...rnment is likely to invoke the compulsory licensin...ble domestic drug //firms to produce and stockpile...seful in combating the global threat against the m... 92 empowers the government to issue CL without re...
...l wall hernias are one of the most common conditio...,000 repairs// performed annually. Although ventra...rences and complications remain a vexing problem. ... consistent risk factor for recurrence after VHR. ...
...Paxton and Colleagues from University of Amsterdam...nt transmission of HIV infection to child. Though ...on of HIV accounts for a large proportion of HIV i...sult of breastfeeding, which requires transfer of ...
... cancer patient made the journey from London to In...cation-Herceptin.// India is likely to attract mo...ving both for surgical procedures and medication.F...ate hospital in Pune for a mastectomy and reconstr...
Other Medicine News:Health News:Predictors Of Wound Infection In Ventral Hernia Repair 2Health News:Breast feeding can prevent HIV infection transmission 2
(Date:7/23/2008)...Newswire-FirstCall/ -- Dendreon Corporation,(Nasda...ependent Data,Monitoring Committee (IDMC) to revie...survival relating to the Company,s Phase 3 IMPACT ...nt, also known as D9902B) clinical trial,of PROVEN...vestigational,active cellular immunotherapy for th...
(Date:7/22/2008)...sults from a multi-center 293-patient European, t... Exchange Symbol: CYT, MONTREAL, July 22 /PRNewsw...e global leader in cryotherapy products to treat c...reviously presented from three,European study cent...(R),were published earlier today in the Journal o...
(Date:7/22/2008)...scuss Development Plan Completed Successfully, DU...marin Corporation,plc (NASDAQ: AMRN ) today annou...at the U.S. Food and Drug Administration (FDA) to ...the treatment of,hypertriglyceridemia. Following t...se 3 with AMR101 in hypertriglyceridemia., Dr. De...
(Date:7/22/2008)...g Lantus(R) and Apidra(R) Resulted in Significant,...s, Whatever the Algorithm ...wire/ -- Results from the "Adjust to,Target in Typ...Carbohydrate,Counting for Adjustment of Mealtime I...rican Diabetes Association,s (ADA) medical journal...
Breaking Medicine Technology:Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 4CryoCath Arctic Front(R) Results Published in JACC 2CryoCath Arctic Front(R) Results Published in JACC 3Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia 2Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia 3Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 2Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 3Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 4ViroPharma to Present at Two Upcoming Healthcare Conferences 1898 1ViroPharma to Present at Two Upcoming Healthcare Conferences 1898 2Story ideas from the Journal of Biological Chemistry 1304 1Story ideas from the Journal of Biological Chemistry 1304 2Serum carcinoembryonic antigen level can reflect adrenal adenoma 6784 1Serum carcinoembryonic antigen level can reflect adrenal adenoma 6784 2Proposal to step up cardiovascular disease research 1299 1Proposal to step up cardiovascular disease research 1299 2
...asound Demonstrates Utility in Evaluating Drug,Eff...ntial for HDL,Therapy , ,PLEASANTON, CA, Mar 30, 2... Sciences, Inc. (NASDAQ: LIPD) Dr. H. Bryan Brewer..., Inc., concluded from,the wide range of presentat...(ACC) Meeting in New Orleans that the rationale fo...
...e Astellas Commitment to Overcoming Critical,Short... April 02, 2007 /PRNewswire/ --Study results,prese...robiology,and Infectious Diseases (ECCMID) show th...icafungin, both have the potential,to meet a signi...pital-acquired infections (HAIs). , Hospital-acqui...
Other Medicine Technology:Presentations at American College of Cardiology Meeting Highlight,New Opportunities for HDL Therapy 2Presentations at American College of Cardiology Meeting Highlight,New Opportunities for HDL Therapy 3Presentations at American College of Cardiology Meeting Highlight,New Opportunities for HDL Therapy 4Presentations at American College of Cardiology Meeting Highlight,New Opportunities for HDL Therapy 5Data on Telavancin and Micafungin Hold Promise of New Therapeutic,Options in Fight Against Serious Infectious Disease 2Data on Telavancin and Micafungin Hold Promise of New Therapeutic,Options in Fight Against Serious Infectious Disease 3Data on Telavancin and Micafungin Hold Promise of New Therapeutic,Options in Fight Against Serious Infectious Disease 4Data on Telavancin and Micafungin Hold Promise of New Therapeutic,Options in Fight Against Serious Infectious Disease 5
Delicate curved shafts with light crisscross serrations. Serrated handle with polished finish. Most popular size or model.
Delicate cross serrated lightly curved tips with serrated handle and polished finish. Most popular size or model.
Delicate lightly curved tips, 1 x 2 mouse style teeth. Serrated handle with polished finish.
Straight tubular shaft with delicate 1.5 mm oval jaws. Squeeze barrel style handle with tip guard and polished finish.
Medicine Products: